Thomas Broome, S.; Fisher, T.; Faiz, A.; Keay, K.A.; Musumeci, G.; Al-Badri, G.; Castorina, A.
Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells. Cells 2021, 10, 1312.
https://doi.org/10.3390/cells10061312
AMA Style
Thomas Broome S, Fisher T, Faiz A, Keay KA, Musumeci G, Al-Badri G, Castorina A.
Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells. Cells. 2021; 10(6):1312.
https://doi.org/10.3390/cells10061312
Chicago/Turabian Style
Thomas Broome, Sarah, Teagan Fisher, Alen Faiz, Kevin A. Keay, Giuseppe Musumeci, Ghaith Al-Badri, and Alessandro Castorina.
2021. "Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells" Cells 10, no. 6: 1312.
https://doi.org/10.3390/cells10061312
APA Style
Thomas Broome, S., Fisher, T., Faiz, A., Keay, K. A., Musumeci, G., Al-Badri, G., & Castorina, A.
(2021). Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells. Cells, 10(6), 1312.
https://doi.org/10.3390/cells10061312